Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749151 · ClinicalTrials.gov registry record · NA
Effectiveness of the American Lung Association Reactive Anti-Smoking Telephone Help Line in Illinois
A NA study, sponsored by Southern Illinois University.
- Completed
- Registry status
- NA
- Development phase
- 990
- Enrollment target
NCT00749151 is a NA study that has completed, run by Southern Illinois University. The registered enrollment target is 990 participants.
The verdict
NCT00749151, a NA study, has completed, sponsored by Southern Illinois University.
- COMPLETED
- Registry status
- NA
- Development phase
- 990 participants
- Enrollment target
Study Summary
An estimated 47 million adult Americans smoke. The American Lung Association has launched a reactive telephone help line to assist in smoking cessation. The proposed study will evaluate its effectiveness in a randomized controlled trial design involving active smokers who call this helpline. Eligible callers will be randomized into two groups: those who receive self-help literature only (i.e. control group) and those who receive additional reactive telephone counseling (i.e. study group). Detailed information will be collected proactively by an independent research calling specialist from all subjects who enroll into the study, by way of follow-up telephone calls, at one, three, six and twelve months following the screen date. The outcome measures to be compared are abstinence rates, quit attempts, changes in extent of smoking and behavioral stage, and cost-effectiveness. A thousand subjects will be enrolled in the two study arms in equal numbers over a period of fifteen months. Intent to treat analysis will be used after adjustment for covariates. The significance of this study lies in establishing the public health importance of such a reactive telephone helpline as a low intensity and low cost interventional smoking cessation tool.
Interventions
- BEHAVIORAL telephone counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 990 participants |
| Start Date | 2002-12 |
| Est. Completion | 2007-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00749151
The ClinicalTrials.gov registry entry for NCT00749151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 990 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern Illinois University, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which telephone counseling is the first listed.
NCT00749151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00749151 about?
NCT00749151 is a clinical study titled "Effectiveness of the American Lung Association Reactive Anti-Smoking Telephone Help Line in Illinois". An estimated 47 million adult Americans smoke. The American Lung Association has launched a reactive telephone help line to assist in smoking cessation. The proposed study will evaluate its effectiveness in a randomized controlled trial design involving active smokers who call this helpline. Eligibl...
What is the current status of trial NCT00749151?
This trial is currently completed. It is a NA study. The enrollment target is 990 participants. The study started on 2002-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00749151?
The interventions under investigation include: telephone counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00749151?
This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.